Browse studies

Find your next paid study

1 recruiting study matching your filters

Saci-IO TNBC: Randomized Phase II Study of Sacituzumab Govitecan With or Without Pembrolizumab in PD-L1-negative Metastatic Triple Negative Breast Cancer (TNBC)

This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative breast cancer (TNBC) that has…

Breast CancerTriple Negative Breast CancerPD-L1 Negative

Dana-Farber Cancer InstituteNCT04468061